Avalyn Pharma, Inc. (AVLN)
26.04
-1.21
(-4.44%)
USD |
NASDAQ |
Oct 23, 16:00
26.04
0.00 (0.00%)
After-Hours: 20:00
Avalyn Pharma Total Assets (Quarterly) : 425.45M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 425.45M |
| Date | Value |
|---|---|
| March 31, 2026 | 135.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 103.90M |
| CorMedix, Inc. | 904.05M |
| Eloxx Pharmaceuticals, Inc. | 63.39M |
| Breakthrough Chemistry, Inc. | 1.300M |
| BioStem Technologies, Inc. | 48.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.10M |
| Shareholders Equity (Quarterly) | 398.35M |
| Debt to Equity Ratio | 0.043 |
| Current Ratio | 33.10 |
| Net Debt Paydown Yield | -0.20% |